DDC created a dynamic business model that includes:

  • Business assumptions that reflect the current market and probable future trends
  • Market study analysis for the DDC drug portfolio performance
  • Manufacturing plan to optimize current technologies
  • Pre-Operational and Operational budget planning
  • Scheduled Financial Statements

THE OPERATING MODEL

GENERIC MANUFACTURING

Primarily manufacturing leading generics

  • Economies of scale
  • Visibility of Opportunities

The capability for multinational pharmaceutical group self-participation in KSA based generic manufacturing.

TOLL MANUFACTURING

Utilizing manufacturing facilities for primary and secondary manufacturing

  • Capacity utilization
  • Support from regulatory framework
  • Strategic continuity
  • Quick Returns

The capability for multinational pharmaceutical group self-participation in KSA based generic manufacturing.